Toll-Like Receptors (TLRs)

### **Toll-Like Receptors (TLRs): Simplified Overview**

Toll-like receptors (TLRs) are proteins that play a crucial role in the **innate immune system**, which is the body’s first line of defense against infections. TLRs act as **pattern recognition receptors (PRRs)**, meaning they identify specific molecules associated with pathogens (**PAMPs**) or signals from damaged cells (**DAMPs**). Once activated, they trigger immune responses to protect the body.

#### **Structure and Location**

• **Structure**: TLRs have three parts:

1. **Extracellular domain**: Recognizes and binds to PAMPs or DAMPs.

2. **Transmembrane domain**: Anchors the receptor to the cell membrane or endosomes.

3. **Cytoplasmic TIR domain**: Initiates signaling inside the cell.

• **Location**:
• **Cell surface TLRs** (e.g., TLR1, TLR2, TLR4): Detect molecules like bacterial lipopolysaccharide (LPS).
• **Endosomal TLRs** (e.g., TLR3, TLR7, TLR9): Recognize viral or bacterial nucleic acids.

#### **Function and Signaling**

When TLRs detect a pathogen or damage signal, they activate signaling pathways via proteins like **MyD88** or **TRIF**, leading to:

1. **NF-κB activation**: Produces inflammatory cytokines (e.g., TNF-α, IL-1β).

2. **IRF activation**: Produces antiviral interferons (e.g., IFN-α, IFN-β).

#### **Clinical Relevance**

• **Gut Health**: TLRs maintain intestinal barrier integrity but may contribute to diseases like **IBD** when dysregulated.
• **Liver Diseases**: In conditions like **ALD** or **NAFLD**, TLR4 is activated by bacterial LPS, causing inflammation and fibrosis.
• **Therapeutic Potential**: Drugs targeting TLRs, such as **TLR4 inhibitors**, and gut microbiome modulation are promising treatments for inflammatory and liver diseases.

TLRs are essential for immunity, but their overactivation can lead to chronic inflammation and disease progression.